Adult T-cell leukemia with elevated serum hyaluronic acid levels paralleling disease activity

• Published in: Rinshō ketsueki Vol. 40; no. 1; p. 51
• Main Authors: Sanada, I, Kawano, F, Tsukamoto, A, Kiyokawa, T
• Format: Journal Article
• Language: Japanese
• Published: Japan 01.01.1999
• Subjects: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols - therapeutic use; Biomarkers, Tumor - blood; Humans; Hyaluronic Acid - blood; Leukemia, T-Cell - blood; Leukemia, T-Cell - drug therapy; Male
• DOI: 10.11406/rinketsu.40.51
• ISSN: 0485-1439

We report on two adult T-cell leukemia (ATL) patients whose levels of serum hyaluronic acid (HA) moved in parallel with the clinical activity of their disease. A 66-year-old man was admitted to our hospital because of unconsciousness and hypotension. Acute type ATL complicated by hypercalcemia and myelofibrosis was diagnosed. Before therapy, the level of patient's serum HA was 2,045 to 4,010 ng/ml (normal range: 50 >). After he achieved complete remission (CR) through chemotherapy, his serum HA was 36 ng/ml. Several months later, however, his ATL relapsed, and his serum HA increased to 393 ng/ml. The other patient was an 80-year-old man who had been admitted on the suspected diagnosis of ATL. Before chemotherapy, his serum HA was high (3,420 ng/ml). After CHOP therapy, he entered CR and his HA decreased to 122 ng/ml. He remains in CR with slightly elevated levels of HA (127 to 212 ng/ml), and is being followed up on an out-patient basis.